May 13, 2005Comparative AdvantageI love TechCentralStation.com. You get an adult daily dose of economics, market news, and junk-science-debunking from a libertarian perspective. The last couple of days have included a few good health care pieces. One discusses European drug manufacturers' choice to focus on generics. This will help them with the bottom line in price-controlled, socialist markets. But this will not provide capital for R&D, so we should not look to the EU nations for any more medical innovation. Another discusses "Activist Medicine." Unlike Activist judges, activist medicine is not necessarily a pejorative, just a reference to using all resources to diagnose and treat every illness. My wife's life was saved six weeks ago by activist medicine but I still see Kling's point: Can we afford to throw everything at every case? But the one that gets excerpted is A Passage to Indian Health Care which describes the advantages of traveling to India for inexpensive, high quality health care. Medical tourism to India started fairly recently when NRIs (non-resident Indians -- those living and working in the West) began to go "home" to India seeking not just their roots, but root canals. They returned with killer smiles and tales of the staggering savings in costs -- even factoring in airfares -- and excellence of treatment. NRIs, aware from their families of India's state-of-the-art technology and the level of surgical skill, also head off "home" for more critical treatment, like kidney transplants, hip replacements and open heart surgery. Indeed, India's 20 million diaspora returning to the US and Britain after successful treatment are India's best ambassadors. Comparative advantage. Free movement of labor and capital. Let India perform non-emergency health care, EU nations manufacture generic drugs and we will have the money to develop new treatments and perform cutting edge emergency medicine at home. Pharmaceuticals Posted by jk at May 13, 2005 6:38 AM |
Now if we could just fix the legal system that installs so many roadblocks in the development and use of new treatments. This is one area where the EU has an advantage over us. They may not get the profit from their drugs, but they don't have as high malpractice costs either. Perhaps the major pharmaceutical companies will develop here, test in Europe and end up selling in India.
Posted by: Silence Dogood at May 13, 2005 12:19 PMActually, India has been utilized as well in the testing arena -- specifically for the reasons you cite. But I would love to test some products on the French and Belgians...
Posted by: jk at May 13, 2005 12:31 PM | What do you think? [2]